Abstract:Alzheimer’s disease (AD) and AD-related dementias (ADRD) are a class of neurodegenerative diseases affecting about 5.7 million Americans. There is no cure for AD/ADRD. Current interventions have modest effects and focus on attenuating cognitive impairment. Detection of patients at high risk of AD/ADRD is crucial for timely interventions to modify risk factors and primarily prevent cognitive decline and dementia, and thus to enhance the quality of life and reduce health care costs. This study seeks to investigate both knowledge-driven (where domain experts identify useful features) and data-driven (where machine learning models select useful features among all available data elements) approaches for AD/ADRD early prediction using real-world electronic health records (EHR) data from the University of Florida (UF) Health system. We identified a cohort of 59,799 patients and examined four widely used machine learning algorithms following a standard case-control study. We also examined the early prediction of AD/ADRD using patient information 0-years, 1-year, 3-years, and 5-years before the disease onset date. The experimental results showed that models based on the Gradient Boosting Trees (GBT) achieved the best performance for the data-driven approach and the Random Forests (RF) achieved the best performance for the knowledge-driven approach. Among all models, GBT using a data-driven approach achieved the best area under the curve (AUC) score of 0.7976, 0.7192, 0.6985, and 0.6798 for 0, 1, 3, 5-years prediction, respectively. We also examined the top features identified by the machine learning models and compared them with the knowledge-driven features identified by domain experts. Our study demonstrated the feasibility of using electronic health records for the early prediction of AD/ADRD and discovered potential challenges for future investigations. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study was partially supported by an Ed and Ethel Moore Alzheimer's Disease Research Program from the Florida Department of Health (FL DOH #9AZ14) and a Patient-Centered Outcomes Research Institute (PCORI) Award (ME-2018C3-14754). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding institutions. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The University of Florida IRB (IRB201900182) had approved this study and assigned to the exempt category. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes Data sharing is not applicable to this article.

Using a newly validated algorithm to estimate prevalence and incidence of Alzheimer’s Disease and related dementias in Medicare claims

Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data

Case Definition for Diagnosed Alzheimer Disease and Related Dementias in Medicare

Prevalence Estimation of Dementia/Alzheimer's Disease Using Health and Retirement Study Database in the United States

Prevalence of Alzheimer’s disease (AD) dementia and mild cognitive impairment (MCI) in the United States Medicare population

Identifying Dementia Severity Among People Living With Dementia Using Administrative Claims Data

Identification of older adults with Alzheimer's and related dementias among patients newly diagnosed with cancer: A comparison of methodological approaches

A comparison of dementia diagnoses and cognitive function measures in Medicare claims and the Minimum Data Set

Prevalence of Mild Cognitive Impairment and Alzheimer's Disease Identified in Veterans in the United States

Analyzing Risk Factors for Post-Acute Recovery in Older Adults with Alzheimer's Disease and Related Dementia: A New Semi-Parametric Model for Large-Scale Medicare Claims

PMU26 HEALTHCARE RESOURCE UTILIZATION AND CLINICAL OUTCOMES IN HOSPITALIZED PATIENTS WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN THE UNITED STATES: A NATIONWIDE RETROSPECTIVE COHORT STUDY

Prevalence and Severity Distribution of Alzheimer’s Disease in the United States from the Health and Retirement Study

Diagnostic rate estimation from Medicare records: Dependence on claim numbers and latent clinical features

Alzheimer's disease and related dementia diagnoses among American Indian and Alaska Native adults aged ≥45 years, Indian Health Service System, 2016-2020

Patterns of national emergency department utilization by fee‐for‐service Medicare beneficiaries with dementia

ADL-dependent older adults were identified in medico-administrative databases

Racial and Ethnic Differences in the Population-Attributable Fractions of Alzheimer Disease and Related Dementias

Early Prediction of Alzheimer’s Disease and Related Dementias Using Electronic Health Records

Data-driven discovery of probable Alzheimer's disease and related dementia subphenotypes using electronic health records

Using Machine Learning and Electronic Health Record (EHR) Data for the Early Prediction of Alzheimer's Disease and Related Dementias.

Using Medicare Enrollment Data to Identify Beneficiaries in Assisted Living